Skip to main content

Our phones will be unavailable on Tuesday 28 March. Please use our ‘Contact us’ webform. We apologise for the inconvenience.

Completion of evaluation of bis-aminopropyl diglycol dimaleate

This is a decorative image only.

We have completed an evaluation about the human health risks associated with the introduction and use of 1-Propanamine, 3,3'-[oxybis(2,1-ethanediyloxy)]bis-, (2Z)-2-butenedioate (1:2) (also known as bis-aminopropyl diglycol dimaleate), which is currently under an assessment certificate.

This evaluation is issued by the AICIS Executive Director under section 73 of the Industrial Chemicals Act 2019 and is listed below. 

Subject of evaluation: 1-Propanamine, 3,3'-[oxybis(2,1-ethanediyloxy)]bis-, (2Z)-2-butenedioate (1:2) (bis-aminopropyl diglycol dimaleate)

CAS number: 1629579-82-3

Proposed means for managing risks: Information relating to safe introduction and use

Download Evaluation Statement: 

Published date
Was this page helpful?
For broken links or technical issues, please provide as much detail as possible. Do not include your name, email address and other personal or commercially sensitive information.

Keep informed with updates